FDA Warning Letters
This article was originally published in The Silver Sheet
Executive Summary
Hospira cited for QS violations in relation to Plum infusion pumps; maker of brachytherapy seeds failed to document complaints of leaking seeds. Seventeen warning letters listed by FDA from Oct. 9 through Nov. 12.